Intranasal Insulin and Post-stroke Cognition: A Pilot Study


Phase N/A Results N/A

Summary of Purpose

Almost two-thirds of survivors have cognitive impairment (CI), manifested as memory, language, and judgement problems. Post-stroke CI at 2 weeks is a significant predictor of long-term functional outcome, and more generally, cognitive impairments have a major impact on functional outcome and ability to participate in rehabilitation. CI is associated with increased systemic inflammation. Intranasally-administered...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 March 2018.

1 Apr 2016 12 Feb 2016 1 Sep 2018 1 Sep 2018 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment